Predictmedix AI and UVTV Digital India Forge Strategic Partnership to Revolutionize Health and Safety in Sports and Worship Venues
Predictmedix AI and UVTV Digital India Forge Strategic Partnership to Revolutionize Health and Safety in Sports and Worship Venues
TORONTO, ON / ACCESSWIRE / February 20, 2024 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix"), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), today announced a strategic alliance with UVTV Digital India, a leading media platform with widespread influence across India. This partnership marks a significant milestone in the quest to redefine health and safety protocols in the rapidly evolving sectors of sports, recreation, hospitality, and religious institutions, aiming to promote a culture of well-being across diverse communities.
安大略省多倫多/ACCESSWIRE/2024年2月20日/由專有人工智能(AI)提供快速健康篩查解決方案的領先提供商Predictmedix AI Inc.(CSE: PMED)(OTCQB: PMED)(FRA: 3QP)(“公司” 或 “Predictmedix”)今天宣佈與印度具有廣泛影響力的領先媒體平台UVTV Digital India建立戰略聯盟。這種夥伴關係標誌着重新定義快速發展的體育、娛樂、酒店和宗教機構等領域的健康和安全協議的一個重要里程碑,旨在促進不同社區的幸福文化。
Expanding the Scope of Health and Safety Innovations:
擴大健康和安全創新的範圍:
In uniting Predictmedix AI's advanced health assessment technologies with UVTV Digital India's broad digital outreach, the partnership is poised to introduce groundbreaking safety measures in sports and religious gatherings, in alignment with India's Health-for-All mission. With India home to over 2.3 million places of worship, this initiative represents a significant business opportunity.1
通過將Predictmedix AI的先進健康評估技術與印度UVTV Digital的廣泛數字推廣相結合,該合作伙伴關係有望在體育和宗教聚會中引入突破性的安全措施,以符合印度的全民健康使命。印度擁有超過230萬個禮拜場所,這一舉措代表着巨大的商機。1
By integrating Predictmedix AI's technology in high-footfall gatherings, UVTV Digital carves out a novel revenue stream. Temples and other venues may adopt health screening services as an added safety measure, enhancing devotee well-being. This approach not only secures a steady income for Predictmedix AI but also cements its status as a frontrunner in health and safety solutions for diverse community needs. The revenue potential extends beyond initial technology implementation to include ongoing services and support, ensuring a sustainable business model. Furthermore, this collaboration heralds Predictmedix AI as an industry innovator, adept at tailoring health technologies to unique settings and positively impacting public health while capitalizing on lucrative business opportunities.
通過將Predictmedix AI的技術整合到高人流量聚會中,UVTV Digital開闢了新的收入來源。寺廟和其他場所可以採用健康檢查服務作爲額外的安全措施,從而提高奉獻者的福祉。這種方法不僅確保了Predictmedix AI的穩定收入,而且鞏固了其作爲滿足不同社區需求的健康和安全解決方案領跑者的地位。潛在的收入不僅限於最初的技術實施,還包括持續的服務和支持,從而確保了可持續的商業模式。此外,此次合作預示着Predictmedix AI將成爲行業創新者,善於爲獨特的環境量身定製健康技術,在利用利潤豐厚的商機的同時,對公共衛生產生積極影響。
UVTV Digital India: Pioneering Digital Transformation for Community Well-being:
UVTV Digital India:開創性數字化轉型促進社區福祉:
UVTV Digital India's role as a digital transformation catalyst is central to the partnership, with its ability to leverage a broad network and digital platform to disseminate Predictmedix AI's health technologies to a wide audience. This collaboration is expected to create safer and healthier environments, making significant strides in public health and safety.
UVTV Digital India作爲數字化轉型催化劑的作用是該合作伙伴關係的核心,它能夠利用廣泛的網絡和數字平台向廣大受衆傳播Predictmedix AI的健康技術。預計這種合作將創造更安全、更健康的環境,在公共健康和安全方面取得重大進展。
A Future Focused on Innovation and Safety:
注重創新和安全的未來:
This strategic partnership between Predictmedix AI and UVTV Digital India signifies a forward-thinking approach to health and safety, setting new standards for public well-being in various community settings. By leveraging advanced AI technologies and digital outreach, the collaboration is set to make a lasting impact on how health and safety measures are implemented, offering a blueprint for future innovations in the field.
Predictmedix AI和UVTV Digital India之間的這種戰略合作伙伴關係標誌着一種前瞻性的健康和安全方針,爲各種社區環境中的公共福祉設定了新的標準。通過利用先進的人工智能技術和數字宣傳,此次合作將對健康和安全措施的實施方式產生持久影響,爲該領域的未來創新提供藍圖。
Rahul Kushwah, COO of Predictmedix AI, expressed enthusiasm about the partnership, stating, "We are excited to partner with UVTV Digital India to bring our advanced health and safety solutions to sports, religious institutions, and places of worship. This partnership stands as a testament to our commitment to enhancing community well-being through innovation."
Predictmedix AI首席運營官拉胡爾·庫什瓦對這種合作表示了熱情,他說:“我們很高興與UVTV Digital India合作,將我們先進的健康和安全解決方案引入體育、宗教機構和禮拜場所。這種夥伴關係證明了我們致力於通過創新增進社區福祉。”
Yugal Kishore Sharma, Founder & CEO of UVTV Digital and an avid sportsman with a rich background in media, telecom, and sports entertainment, brings a unique perspective to the partnership. As the Founder & Director of Sportism and the vBelieve Sports initiative-India's first e-social enterprise for sports development-Sharma is deeply committed to granting every child their 'right to play.' Additionally, his roles as the Promoter & Director of India's premier Football Club, HINDUSTAN FC, established in 1948, and Director of the Esports Federation of India, underscore his dedication to sports and community health. Sharma remarked, "incorporating health and safety measures is crucial, especially in dynamic environments like sports and places of worship. UVTV Digital India is excited to collaborate with Predictmedix AI to pioneer their cutting-edge-health-assessment-disruptive-technology along-with UVTV Digital's innovatively bundled solution offerings that prioritize the health of the citizens of our glorious Nation."
UVTV Digital的創始人兼首席執行官尤加爾·基肖爾·夏爾馬是一位狂熱的運動員,擁有豐富的媒體、電信和體育娛樂背景,爲合作帶來了獨特的視角。作爲 Sportism 和 vBelieve Sports Initiative(印度第一家體育發展電子社交企業)的創始人兼董事,夏爾馬堅定地致力於賦予每個孩子的 “遊戲權”。此外,他作爲印度首屈一指的足球俱樂部印度斯坦足球俱樂部(成立於1948年)的發起人和董事以及印度電子競技聯合會的主任,這凸顯了他對體育和社區健康的奉獻精神。夏爾馬說:“納入健康和安全措施至關重要,尤其是在體育和禮拜場所等動態環境中。UVTV Digital India很高興與Predictmedix AI合作,開創其尖端的健康評估顛覆性技術,以及UVTV Digital的創新捆綁解決方案產品,這些解決方案優先考慮我們光榮國家公民的健康。”
To receive company news, please sign up for alerts at the bottom of the page link below:
要接收公司新聞,請在頁面底部註冊接收提醒,鏈接如下:
1
1
About UVTV Digital Pvt Ltd ()
關於 UVTV Digital Pvt Ltd ()
UVTV Digital Pvt Ltd., a subsidiary of EKAM CONVERGENCE PVT LTD., part of the 'Integrated Digital Convergent Services Platform-as-a-Service (P-a-a-S) model, holds a 'Unified License ISP Category 'A' for PAN India Services'; 'Multi-System Operator (MSO) License for CATV / IPTV Services across PAN India'; 'Voice Access License for Telephony' and 'Infrastructure Provider IP'1' Category 1 License for Underground Fibre Network Infrastructure.'
UVTV Digital Pvt Ltd. 是 EKAM CONVERGENCE PVT LTD. 的子公司,是 “綜合數字融合服務平台即服務(P-a-a-S)模式” 的一部分,持有 “泛印度服務統一許可證”;“泛印度各地有線電視/IPTV服務的多系統運營商(MSO)許可證”;“電話語音接入許可證” 和 “基礎設施提供商IP1” '地下光纖網絡基礎設施的1類許可證。'
UVTV Digital is an innovative media-tech platform transforming the digital entertainment landscape through its online digital video streaming platform and OTT App dedicated to deliver an enriching, engaging, entertaining, edutainment high-quality content to democratize local and hyperlocal content across colloquial dialects in small towns & cities of urban Bharat.
UVTV Digital是一個創新的媒體技術平台,通過其在線數字視頻流媒體平台和OTT應用程序改變了數字娛樂格局,致力於提供豐富、引人入勝、具有娛樂性的高質量內容,以在巴拉特城市的小城鎮和城市中使用口語方言實現本地和超本地化內容的民主化。
About Predictmedix AI Inc.
關於 Predictmedix AI Inc.
Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) is an emerging provider of rapid health screening and remote patient care solutions globally. The Company's Safe Entry Stations - powered by a proprietary artificial intelligence (AI) - use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including 19 physiological vital parameters, impairment by drugs or alcohol, fatigue, or various mental illnesses. Predictmedix AI's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes. To learn more, please visit our website at or follow us on Twitter, Instagram or LinkedIn.
Predictmedix AI Inc.(CSE: PMED)(OTCQB: PMED)(FRA: 3QP)是全球快速健康篩查和遠程患者護理解決方案的新興提供商。該公司的安全入口站由專有的人工智能(AI)提供支持,使用多光譜攝像機分析生理數據模式並預測各種健康問題,包括19種生理重要參數、藥物或酒精損傷、疲勞或各種精神疾病。Predictmedix AI專有的遠程患者護理平台爲醫療專業人員提供了一套基於人工智能的工具,以改善患者的健康狀況。要了解更多信息,請訪問我們的網站或在推特、Instagram或LinkedIn上關注我們。
Public Relations Contact
公共關係聯繫人
For further media information or to set up an interview, please contact:
欲了解更多媒體信息或安排採訪,請聯繫:
Nelson Hudes
Communications International (905) 660 9155
Nelson@hudescommunications.com
納爾遜·哈德斯
通信國際 (905) 660 9155
Nelson@hudescommunications.com
Dr. Rahul Kushwah (647) 889 6916
Rahul Kushwah 博士 (647) 889 6916
Caution Regarding Forward-Looking Information:
關於前瞻性信息的注意事項:
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results of the Company. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management's reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances. The Company's securities have not been registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or "U.S. Persons", as such term is defined in Regulations under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful. Additionally, there are known and unknown risk factors which could cause the Company's actual results, performance or achievements to be materially different from any Page 4 of 4 future results, performance or achievements expressed or implied by the forward-looking information contained herein, such as, but not limited to dependence on obtaining regulatory approvals; the ability to obtain intellectual property rights related to its technology; limited operating history; general business, economic, competitive, political, regulatory and social uncertainties, and in particular, uncertainties related to COVID-19; risks related to factors beyond the control of the Company, including risks related to COVID-19; risks related to the Company's shares, including price volatility due to events that may or may not be within such party's control; reliance on management; and the emergency of additional competitors in the industry.
本新聞稿可能包含前瞻性陳述和基於當前預期的信息。這些陳述不應被視爲對公司未來業績或業績的保證。此類陳述涉及已知和未知的風險、不確定性和其他因素,這些因素可能導致實際業績、業績或成就與此類陳述所暗示的結果存在重大差異。儘管此類陳述基於管理層的合理假設,但無法保證此類假設會被證明是正確的。我們不負責更新或修改它們以反映新的事件或情況。公司的證券尚未根據經修訂的1933年《美國證券法》(“美國證券法”)或適用的州證券法進行註冊,如果沒有註冊或不受此類註冊要求的適用豁免,則不得向在美國的人或 “美國個人”(該術語的定義見美國證券法的法規)發行或出售,也不得爲他們的賬戶或利益發行或出售。本新聞稿不構成出售要約或招攬買入要約,也不得在美國或任何此類要約、招攬或出售非法的司法管轄區出售證券。此外,還有一些已知和未知的風險因素可能導致公司的實際業績、業績或成就與本文件所含前瞻性信息所表達或暗示的未來業績、業績或成就存在重大差異,例如但不限於依賴獲得監管部門批准;獲得與其技術相關的知識產權的能力;運營歷史有限;一般商業、經濟、競爭、政治、監管和社會不確定性,以及特別是與 COVID-19 相關的不確定性;與公司無法控制的因素相關的風險,包括與 COVID-19 相關的風險;與公司股票相關的風險,包括該方可能也可能無法控制的事件導致的價格波動;對管理層的依賴;以及該行業其他競爭對手的緊急情況。
All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except required by law.
本文中的所有前瞻性信息均受本警示聲明的全面限制,除非法律要求,否則公司不承擔任何修改或更新任何此類前瞻性信息或公開宣佈爲反映未來業績、事件或發展而對本文包含的任何前瞻性信息進行任何修訂的結果的義務。
Disclaimer: "The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.
免責聲明:“公司目前並未明確或暗示其產品有能力診斷、消除、治癒或遏制 COVID-19(或 SARS-2 冠狀病毒)。
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED NOR DOES IT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
加拿大證券交易所尚未審查本新聞稿的充分性或準確性,也不承擔任何責任。
SOURCE: Predictmedix AI Inc.
來源:Predictmedix AI Inc.